Study: Immunocompromised patients report fewer negative effects after COVID-19 mRNA vaccine booster
Immunocompromised people age 12 and older experience fewer local and systemic reactions after receiving a COVID-19 mRNA booster than after the third primary dose, the Centers for Disease Control and Prevention reports. The findings are based on responses to CDC’s voluntary V-safe virtual health check-in platform and Vaccine Adverse Event Reporting System.
Related News Articles
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…